Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:RETA

Reata Pharmaceuticals (RETA) Stock Price, News & Analysis

Reata Pharmaceuticals logo

About Reata Pharmaceuticals Stock (NASDAQ:RETA)

Advanced Chart

Key Stats

Today's Range
$172.36
$172.36
50-Day Range
$168.70
$172.36
52-Week Range
$21.83
$172.46
Volume
N/A
Average Volume
1.09 million shs
Market Capitalization
$6.58 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RETA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Reata Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

RETA Stock News Headlines

HIDDEN IN THE BOOK OF GENESIS…
“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.
See More Headlines

RETA Stock Analysis - Frequently Asked Questions

Reata Pharmaceuticals, Inc. (NASDAQ:RETA) announced its quarterly earnings results on Monday, November, 8th. The company reported ($1.97) earnings per share for the quarter, topping analysts' consensus estimates of ($2.32) by $0.35. Reata Pharmaceuticals's quarterly revenue was up 428.6% on a year-over-year basis.

Reata Pharmaceuticals (RETA) raised $60 million in an initial public offering on Thursday, May 26th 2016. The company issued 4,000,000 shares at $14.00-$16.00 per share. Citigroup, Cowen and Company and Piper Jaffray acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Reata Pharmaceuticals investors own include NVIDIA (NVDA), Meta Platforms (META), CrowdStrike (CRWD), Advanced Micro Devices (AMD), Netflix (NFLX), Approach Resources (AREX) and Intel (INTC).

Company Calendar

Last Earnings
11/08/2021
Today
8/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:RETA
CIK
1358762
Fax
N/A
Employees
321
Year Founded
2002

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$311.90 million
Net Margins
N/A
Pretax Margin
-373.40%
Return on Equity
-922.50%
Return on Assets
-73.39%

Debt

Debt-to-Equity Ratio
0.84
Current Ratio
3.21
Quick Ratio
3.19

Sales & Book Value

Annual Sales
$23.48 million
Price / Sales
280.05
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1.79) per share
Price / Book
-96.29

Miscellaneous

Outstanding Shares
38,150,000
Free Float
27,926,000
Market Cap
$6.58 billion
Optionable
Optionable
Beta
1.42

Social Links

10 Stocks Set to Soar in Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:RETA) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners